APA

Wyatt R. M., Fraser I., Welty N., Lord B., Wennerholm M., Sutton S., Ameriks M. K., Dugovic C., Yun S., White A., Nguyen L., Koudriakova T., Tian G., Suarez J., Szewczuk L., Bonnette W., Ahn K., Ghosh B., Flores C. M., Connolly P. J., Zhu B., Macielag M. J., Brandt M. R., Chevalier K., Zhang S., Lovenberg T. & Bonaventure P. (20200706). Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. : The Journal of pharmacology and experimental therapeutics.

Chicago

Wyatt Ryan M, Fraser Ian, Welty Natalie, Lord Brian, Wennerholm Michelle, Sutton Steven, Ameriks Michael K, Dugovic Christine, Yun Sujin, White Allison, Nguyen Leslie, Koudriakova Tatiana, Tian Gaochao, Suarez Javier, Szewczuk Lawrence, Bonnette William, Ahn Kay, Ghosh Brahma, Flores Christopher M, Connolly Peter J, Zhu Bin, Macielag Mark J, Brandt Michael R, Chevalier Kristen, Zhang Sui-Po, Lovenberg Timothy and Bonaventure Pascal. 20200706. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. : The Journal of pharmacology and experimental therapeutics.

Harvard

Wyatt R. M., Fraser I., Welty N., Lord B., Wennerholm M., Sutton S., Ameriks M. K., Dugovic C., Yun S., White A., Nguyen L., Koudriakova T., Tian G., Suarez J., Szewczuk L., Bonnette W., Ahn K., Ghosh B., Flores C. M., Connolly P. J., Zhu B., Macielag M. J., Brandt M. R., Chevalier K., Zhang S., Lovenberg T. and Bonaventure P. (20200706). Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. : The Journal of pharmacology and experimental therapeutics.

MLA

Wyatt Ryan M, Fraser Ian, Welty Natalie, Lord Brian, Wennerholm Michelle, Sutton Steven, Ameriks Michael K, Dugovic Christine, Yun Sujin, White Allison, Nguyen Leslie, Koudriakova Tatiana, Tian Gaochao, Suarez Javier, Szewczuk Lawrence, Bonnette William, Ahn Kay, Ghosh Brahma, Flores Christopher M, Connolly Peter J, Zhu Bin, Macielag Mark J, Brandt Michael R, Chevalier Kristen, Zhang Sui-Po, Lovenberg Timothy and Bonaventure Pascal. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor. : The Journal of pharmacology and experimental therapeutics. 20200706.